Literature DB >> 15523172

Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis.

Yoshikatsu Kaneko1, Masako Iwano, Hitomi Yoshida, Miyoko Kosuge, Sanae Ito, Ichiei Narita, Fumitake Gejyo, Masashi Suzuki.   

Abstract

BACKGROUND: Thrombotic occlusion is a frequent complication of central venous catheters used to provide temporary blood access on hemodialysis therapy. Heparin-lock is conventionally used to maintain patency of the catheter, but the necessity of heparin-lock has not been determined yet.
METHODS: After the immobilized-urokinase double-lumen central venous catheter was inserted into 48 Japanese hemodialysis patients, 22 patients randomized to the heparin group received a 20-ml saline-flush, followed by 2 ml of 1,000 U/ml heparin-lock, and 26 patients randomized to the saline group received only the 20-ml saline-flush once a day for each lumen.
RESULTS: Thrombotic occlusion was observed in only 1 out of 22 patients in the heparin group and 1 out of 26 patients in the saline group. No significant difference of the catheter survival was observed between the two groups (p = 0.8599).
CONCLUSIONS: Natural saline-flush is sufficient for maintaining the patency of an immobilized-urokinase double-lumen central venous catheter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523172     DOI: 10.1159/000081811

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

1.  Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.

Authors:  Natalie K Bradford; Rachel M Edwards; Raymond J Chan
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

Review 2.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 3.  Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.

Authors:  Ying Wang; Jessica N Ivany; Vlado Perkovic; Martin P Gallagher; Mark Woodward; Meg J Jardine
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04

Review 4.  Interventions for treating central venous haemodialysis catheter malfunction.

Authors:  Alice L Kennard; Giles D Walters; Simon H Jiang; Girish S Talaulikar
Journal:  Cochrane Database Syst Rev       Date:  2017-10-26

Review 5.  Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.

Authors:  Lei Zhong; Hai-Li Wang; Bo Xu; Yao Yuan; Xin Wang; Ying-Ying Zhang; Li Ji; Zi-Mu Pan; Zhan-Sheng Hu
Journal:  Crit Care       Date:  2017-01-08       Impact factor: 9.097

Review 6.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30

7.  Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial.

Authors:  Ali Akbar Beigi; Mirhadi Seyed HadiZadeh; Fereshteh Salimi; Hafez Ghaheri
Journal:  Adv Biomed Res       Date:  2014-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.